An Audit to Evaluate the Clinical Safety and PSA Response of Firmagon® (Degarelix) in Patients With Advanced Metastatic Prostate Cancer -. J. Can. Res. Updates 2013, 2 (1),  21-25. https://doi.org/10.6000/1929-2279.2013.02.01.4.